Designed to merge ideas with investment, NobleCon18 (the first full in-person NobleCon since February 2020) will feature 100+ carefully selected emerging growth public companies. With total attendance limited to 1,000, this ideal-sized event will provide investors with more direct access to executive teams over the course of the two-day conference. Taking place at The Guitar […]

Texas-based CNS Pharmaceuticals is a novel brain cancer drug developer that is building a series of global clinical trials for its lead drug candidate, Berubicin CNS began dosing patients in a global trial last September to evaluate Berubicin in treating glioblastoma multiforme (“GBM”), currently an incurable brain cancer CNS received FDA Fast Track designation for […]

TCCR closed on acquisitions of subsidiaries Correlate and Solar Site Design on December 28, 2021 The company has filed with the SEC to change its name to Correlate Infrastructure Partners Inc. TCCR subsidiaries have a project pipeline of over $100 million, with more than $20 million in awarded backlog The company’s total addressable market is […]

HENC is focusing on expansion of current operations, future growth in industry Company aims to be a low-cost, nationally and internationally branded company, become true multistate operator (“MSO”) Recent podcast provides overview of company’s strategic plans, important milestones Key acquisitions and investments have played an essential role in Hero Technologies’ (OTC: HENC)  strategic business plan and […]

Air purifiers can improve indoor air quality, help soothe allergy and asthma symptoms, and rid air of toxins. Kronos’s proprietary, medical-grade technology has been tested as the most effective clean-air solution on the market. An air purifier “may be the household investment to make this year” (“USA Today”) The global pandemic has drawn attention to […]

Life science executives are invited to attend the 2nd Real World Evidence and Market Access Symposium being held as a virtual event on April 11-12, 2022. The event is hosted by DGE, a leading global event management company that caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, health care, medical devices, […]

While appearing on The Jesse Tee Show, the company’s co-founder and CEO, Matt Stang, shared his professional background, Delic’s history, its growth, and its plans going forward Mr. Stang attributes its success to understanding where opportunities and people connect, how to make things win-win for all people, and giving customers value Founded in 2016, Delic […]

Artificial intelligence-enhanced security devices and big data collection are gaining popularity as means for strengthening companies’ footprints, particularly in response to criminal activity that can otherwise weaken operations Knightscope is a Silicon Valley-based company developing Autonomous Security Robots (“ASRs”) in response to America’s security needs, delivering a variety of models that observe and report on […]

Novel drug development company Mydecine Innovations Group is focusing on a medicinal pipeline for psychedelic drug candidates that have established some efficacy in treating mental illnesses — specifically addiction Mydecine is progressing in its clinical trial evaluation of its lead candidate, MYCO-001, and is finalizing an IND application with the FDA to begin patient dosing […]

Fintech, Healthcare, pharma, technology, finance, infrastructure, and allied companies and investors are invited to attend the Virtual Growth Conference, being held on March 28-30, 2022, as a virtual event. The year 2022 opens up opportunities for traders and investors and this Virtual Growth Conference 2022 offers the perfect stage for networking and understanding the future […]